are glp 1 agonists safe GLP-1 for Weight Loss: or Risky? GLP-1 Agonists in Cardiovascular Diseases:
Description
Aids sustainable weight management
Recently, the introduction of highly effective glucagon-like peptide-1 (GLP-1) receptor agonists has led to increased utilization of obesity medications in this population
Results In total, 204 cases of SSIBs associated with GLP-1RAs, including semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, were identified in the FAERS database
What impact will they have over the next 5 years?
SGLT-2 inhibitors are superior to GLP-1RA in reducing the risk of HHF and renal events
